TY - JOUR
T1 - The role of Twist1 in mutant huntingtin–induced transcriptional alterations and neurotoxicity
AU - Pan, Yanchun
AU - Zhu, Ying
AU - Yang, Wei
AU - Tycksen, Eric
AU - Liu, Shaopeng
AU - Palucki, John
AU - Zhu, Linjian
AU - Sasaki, Yo
AU - Sharma, Mukesh K.
AU - Kim, Albert H.
AU - Zhang, Bo
AU - Yano, Hiroko
N1 - Funding Information:
This work was supported by National Institutes of Health Grants K01 AG033724 (to H. Y.), R21 NS096603 (to H. Y.), R01 NS094670 (to A. H. K.), the McDonnell Center for Cellular and Molecular Neurobiology at Washington University, and the Hope Center for Neurological Disorders at Washington University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
Acknowledgments—We thank the members of the Yano and Kim laboratories for helpful discussions and technical support. We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is supported in part by NCI, National Institutes of Health (NIH), Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant UL1TR000448 from the National Center for Research Resources (NCRR)/NIH and the NIH Roadmap for Medical Research.
Funding Information:
This work was supported by National Institutes of Health Grants K01 AG033724 (to H. Y.), R21 NS096603 (to H. Y.), R01 NS094670 (to A. H. K.), the McDonnell Center for Cellular and Molecular Neurobiology at Washington University, and the Hope Center for Neurological Disorders at Washington University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank the members of the Yano and Kim laboratories for helpful discussions and technical support. We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is supported in part by NCI, National Institutes of Health (NIH), Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant UL1TR000448 from the National Center for Research Resources (NCRR)/NIH and the NIH Roadmap for Medical Research.
Publisher Copyright:
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2018/7/27
Y1 - 2018/7/27
N2 - Huntington’s disease (HD) is a fatal neurodegenerative disorder caused by an abnormal expansion of polyglutamine repeats in the huntingtin protein (Htt). Transcriptional dysregulation is an early event in the course of HD progression and is thought to contribute to disease pathogenesis, but how mutant Htt causes transcriptional alterations and subsequent cell death in neurons is not well understood. RNA-Seq analysis revealed that expression of a mutant Htt fragment in primary cortical neurons leads to robust gene expression changes before neuronal death. Basic helix-loop-helix transcription factor Twist1, which is essential for embryogenesis and is normally expressed at low levels in mature neurons, was substantially up-regulated in mutant Htt–expressing neurons in culture and in the brains of HD mouse models. Knockdown of Twist1 by RNAi in mutant Htt–expressing primary cortical neurons reversed the altered expression of a subset of genes involved in neuronal function and, importantly, abrogated neurotoxicity. Using brain-derived neurotrophic factor (Bdnf), which is known to be involved in HD pathogenesis, as a model gene, we found that Twist1 knockdown could reverse mutant Htt–induced DNA hypermethylation at the Bdnf regulatory region and reactivate Bdnf expression. Together, these results suggest that Twist1 is an important upstream mediator of mutant Htt–induced neuronal death and may in part operate through epigenetic mechanisms.
AB - Huntington’s disease (HD) is a fatal neurodegenerative disorder caused by an abnormal expansion of polyglutamine repeats in the huntingtin protein (Htt). Transcriptional dysregulation is an early event in the course of HD progression and is thought to contribute to disease pathogenesis, but how mutant Htt causes transcriptional alterations and subsequent cell death in neurons is not well understood. RNA-Seq analysis revealed that expression of a mutant Htt fragment in primary cortical neurons leads to robust gene expression changes before neuronal death. Basic helix-loop-helix transcription factor Twist1, which is essential for embryogenesis and is normally expressed at low levels in mature neurons, was substantially up-regulated in mutant Htt–expressing neurons in culture and in the brains of HD mouse models. Knockdown of Twist1 by RNAi in mutant Htt–expressing primary cortical neurons reversed the altered expression of a subset of genes involved in neuronal function and, importantly, abrogated neurotoxicity. Using brain-derived neurotrophic factor (Bdnf), which is known to be involved in HD pathogenesis, as a model gene, we found that Twist1 knockdown could reverse mutant Htt–induced DNA hypermethylation at the Bdnf regulatory region and reactivate Bdnf expression. Together, these results suggest that Twist1 is an important upstream mediator of mutant Htt–induced neuronal death and may in part operate through epigenetic mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=85050722336&partnerID=8YFLogxK
U2 - 10.1074/jbc.RA117.001211
DO - 10.1074/jbc.RA117.001211
M3 - Article
C2 - 29891550
AN - SCOPUS:85050722336
SN - 0021-9258
VL - 293
SP - 11850
EP - 11866
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 30
ER -